Share this article
Share this article
SAN FRANCISCO, May 4, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the first quarter ended March 31, 2021 signaling continued momentum into 2021. We had a very strong start to the year, experiencing record daily volumes, and we expect that momentum to continue into the coming years, said Sean George, co-founder and chief executive officer of Invitae. Genetic information is the foundation for personalized medicine, and we believe Invitae is uniquely positioned to deliver that information from a single platform across all stages of life, ushering personalized medicine into the mainstream to improve healthcare for all.
Solving the Mystery of New Guinea’s Highland Wild Dogs Research pointing to origins of this rare canine could aid conservation efforts. Richard Pallardy
April 30, 2021
The highlands of New Guinea echo with strange, whale-like howls. These ghostly vocalizations emanate from an unexpected source. Improbably, a little-known canine prowls the steep mountains that bisect the world’s second-largest island, picking its way along treacherous outcrops and extracting a living from some of the least explored terrain on the planet.
A New Guinea highland wild dog captured on film by a camera trap. The dogs were feared extinct in their native range until 2012. Photo by James McIntyre, New Guinea Highland Wild Dog Foundation.
Credit: Genome 10K Project
Study Take-Aways Unprecedented novel discoveries have implications for characterizing biodiversity for all life, conservation, and human health and disease.
o This finding provides novel avenues of research to increase immune defenses, particularly relevant for emerging infectious diseases, such as the current COVID-19 pandemic. The flagship paper presented whole genome sequence analyses of 16 vertebrate species to illustrate high quality, near error free, near complete, low cost reference genome assemblies.
o Though near 400 species have been sequenced at some level, the quality today reflects a quantum leap in precision sequence details and discovery.
FORT LAUDERDALE/DAVIE, Fla. - Two decades ago, the full genome sequence of humankind was released. It was funded by international government and philanthropic sources at a cost of billions of dollars.
Howard Hughes Medical Institute (HHMI) Investigator Erich Jarvis and members of the Vertebrate Genome Project (VGP) published high-quality genomes of 25 species, a milestone in an effort to read the complete genetic sequences of every known vertebrate species.
E-Mail
NEW YORK, NY Diagnosing chronic kidney disease, which is often undetected until it causes irreversible damage, may soon become automated with a new algorithm that interprets data from electronic medical records.
The algorithm, developed by researchers at Columbia University Vagelos College of Physicians and Surgeons, automatically scours a patient s electronic medical record for results of blood and urine tests and, using a mix of established equations and machine learning to process the data, can alert physicians to patients in the earliest stages of chronic kidney disease.
A study of the algorithm was published in the journal
npj Digital Medicine in April.